CELLULAR DETERMINANTS OF SENSITIVITY AND RESISTANCE TO DNA TOPOISOMERASE INHIBITORS

被引：246

作者：

POMMIER, Y

LETEURTRE, F

FESEN, MR

FUJIMORI, A

BERTRAND, R

SOLARY, E

KOHLHAGEN, G

KOHN, KW

机构：

[1] Laboratory of Molecular Pharmacology (DTP, DCT), National Cancer Institute, National Institutes of Health, Bethesda, MD

来源：

CANCER INVESTIGATION | 1994年 / 12卷 / 05期

关键词：

D O I：

10.3109/07357909409021413

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：530 / 542

页数：13

共 116 条

[71] CATALYTIC FUNCTION OF DNA TOPOISOMERASE-II [J].

OSHEROFF, N ;

ZECHIEDRICH, EL ;

GALE, KC .

BIOESSAYS, 1991, 13 (06) :269-275

[72]

PATEL S, 1990, ANTI-CANCER DRUG DES, V5, P149

[73]

PODDEVIN B, 1993, MOL PHARMACOL, V44, P767

[74] LOCAL BASE SEQUENCE PREFERENCES FOR DNA CLEAVAGE BY MAMMALIAN TOPOISOMERASE-II IN THE PRESENCE OF AMSACRINE OR TENIPOSIDE [J].

POMMIER, Y ;

CAPRANICO, G ;

ORR, A ;

KOHN, KW .

NUCLEIC ACIDS RESEARCH, 1991, 19 (21) :5973-5980

[75]

POMMIER Y, 1992, CANCER RES, V52, P3125

[76] EFFECTS OF DNA INTERCALATING AGENTS ON TOPOISOMERASE-II INDUCED DNA STRAND CLEAVAGE IN ISOLATED MAMMALIAN-CELL NUCLEI [J].

POMMIER, Y ;

SCHWARTZ, RE ;

ZWELLING, LA ;

KOHN, KW .

BIOCHEMISTRY, 1985, 24 (23) :6406-6410

[77]

POMMIER Y, 1993, MOLECULAR BIOLOGY OF DNA TOPOISOMERASES AND ITS APPLICATION CHEMOTHERAPY, P215

[78]

POMMIER Y, 1985, CANCER RES, V45, P3143

[79]

POMMIER Y, 1993, CAUSES CONSEQUENCES, P277

[80]

Pommier Y., 1991, DNA TOPOISOMERASES C, P121

← 3 4 5 6 7 8 9 10 11 12 →